Dr. James S. Lewis
Serving Philadelphia, Bucks County, Elkins Park, Conshohocken LASIK Patients
Dr. James Lewis from Philadelphia, Pennsylvania presented on Sunday, during the ASCRS Paper Session entitled "Intraocular Surgery-Correcting IOLs," the updated findings of STAAR's Collamer Accommodation Study Team (CAST).
04.12.2010 PR Newswire United Business Media
click image to read article
Focus on the LASIK flap's Creation:
POINT/COUNTERPOINT: IS IT SAFER TO CREATE THE LASIK FLAP WITH FEMTOSECOND TECHNOLOGY THAN A MECHANNICAL MICROKERATOME?
click image to read article
The Optimal Choice for Sub Bowman's Keratomileusis
click image to read article
Ophthalmology Times featuring James S. Lewis, MD
click image to read article
Correcting Your Vision with Laser Surgery
has been published. Dr. James Lewis contributes to this volume.
click image to read article
Bladeless Corneal Transplantation News
Ocular Surgery News
Microkeratomes are here to stay
My ideal femtosecond laser would be small enough to fit under my excimer platform and eliminate the need to move patients from one device to another; rarely need service and when necessary the manufacturer could ship me a loaner unit overnight; not leave tissue bridges and therefore allow me to lift all flaps atraumatically; not leave air bubbles in the stroma or anterior chamber and would never produce a surgical delay or prevent iris registration; produce almost no inflammation and would not require intensive topical steroids; consistently create perfect flaps between 95 µm and 105 µm with a 3.5-mm hinge and 8.5-mm diameter; be almost devoid of diffuse lamellar keratitis; be disposable and portable; and not have a click fee. Last but not least, it would cost under $40,000, have an annual maintenance contract less than $4,000, and cost less than $100 to operate per case.
Read the entire COUNTER Point by James S. Lewis, MD
PCON SuperSite
Thinner flaps
I could see the flaps were 30% thinner using the One Use-Plus SBK than what I had ever achieved with a mechanical microkeratome. The device required no learning curve and provided good consistency, reproducibility and ease of use.
Read more by James S. Lewis, MD; Marcus Devlin, OD
Now Playing on YouTube.com
jslewisMDPC has a growing library of video files for you to watch on youtube.com
This movie clip is showing a Thin-Flap LASIK procedure: SBK in high definition
This movie is a showing the Epi-LASIK procedure proformed by Dr. Lewis: Advanced Surface Ablation in high definition.
Salus University is PCO's new name
On July 1, 2008, PCO will become Salus University
Salus, Latin for health and well-being, is a fitting name for an institution dedicated to educating caring professionals for the health care, teaching and rehabilitation fields.
FDA Recalls LASIK Treatment Algorithms
FDA Recalls LASIK Treatment Algorithms
In April 2007, Cataract & Refractive Surgery Today reported that Alcon Refractive Horizons Inc. (Orlando, FL) issued a safety alert for the Ladar6000 excimer laser. Surgeons were directed to discontinue using the laser for myopic CustomCornea procedures (Alcon Laboratories, Inc., Fort Worth, TX) due to reports that the laser was creating central islands in patients' corneas.
This week, the FDA issued a Class 1 recall for the CustomCornea algorithms used by the Ladar6000 laser to correct myopia with (M3) and without (A7) astigmatism.? According to the FDA's notice, these algorithms "caused corneal abnormalities ('central islands') … [and] resulted in decreased visual sharpness (visual acuity)." The agency warned that these adverse effects may not be correctable with additional laser-based surgery or with eyeglasses or contact lenses.
At press time, Alcon Laboratories had deactivated the recalled algorithms in all of the Ladar6000 lasers in the US.
1. 1. FDA Web site. Class I recall: Alcon Refractive Horizons, Inc. Ladar6000 excimer laser system. Available at: www.fda.gov/cdrh/recalls/recall-022107.html. Accessed June 14, 2007.
Dr. Lewis DOES NOT USE THIS LASER!!!!! OR THESE Algorithms!!!!
Tiger Woods has had an Enhancement
Click here to see the article in Golf Digest. *article has expired
Eyes of Tiger Woods is one of many tour players who have had LASIK laser eye surgery. Has it helped their games, and can it help yours?
New faster Server
check out the new speed any Wednesday..click here
Visian ICL granted FDA Approval
Ocular Surgery News - TOP STORIES 12/27/2005
Visian ICL granted FDA approval
MONROVIA, Calif. — An implantable, foldable collamer lens for the correction of myopia has been granted regulatory approval in the United States, according to the device’s marketer.
STAAR Surgical’s Visian ICL “allows an incision up to 50% smaller than competing technology, and its placement in the eye behind the iris provides a more aesthetically pleasing outcome,” the company said in a press release. The lens received Food and Drug Administration approval for the correction of myopia in adults, STAAR added.
STAAR said it will begin shipping the phakic IOL to “trained doctors” in 6 to 8 weeks. The lens is already approved for sale in 41 countries, including those in the European Union. STAAR said the lens has been implanted in more than 40,000 eyes worldwide.
“We believe the ICL offers patients and their doctors opportunities to achieve higher quality visual outcomes compared with competing technology, and this characteristic will be an important growth driver of the refractive phakic implant market,” said David Bailey, president and chief executive officer of STAAR.
The Visian ICL is a refractive phakic implant intended for placement in the posterior chamber of the eye. The approved models are indicated for the correction of myopia in adults with myopia ranging from –3 D to no more than –15 D with astigmatism no more than 2.5 D at the spectacle plane, and the reduction of myopia in adults with myopia ranging from –15 D to –20 D with astigmatism no more than 2.5 D at the spectacle plane, in patients 21 to 45 years of age with anterior chamber depth of 3 mm or greater, and a stable refractive history within 0.5 D for 1 year prior to implantation, STAAR said.
Mr. Bailey said more than 860 surgeons have completed the first phase of training, which focuses on correct technique.
STAAR said training courses and educational symposia will be a focus for the company at upcoming industry conferences, such as the Royal Hawaiian Eye Meeting next month in Maui.
Copyright ®2005 SLACK Incorporated. All rights reserved.
OSN Supersite link
Climate control
Make sure the facility you choose maintains a constant environment for their laser.
We have moved. Please note our new location.
Our NEW Location in Elkins Park:
Breyer Office Park
8380 Old York Rd. Suite 110A
Elkins Park, PA 19027
The FDA has approved this reversible
alternative to LASIK and clear lens exchange.
Intraocular Contact Lenses receives Approval
by the Advisory Panel of the FDA
Dr. Lewis expects to offer this LASIK-alternative to his patients before the end of the year. Patients who can't have LASIK or who don't want laser corneal surgery will benefit from this breakthrough. The Intraocular Contact Lens (ICL) is inserted in a five minute procedure. No removal, cleaning, maintenance, or replacement is necessary. In fact, patients forget the ICL is inside. The benefits include natural vision without fluctuation, dry eye, or the risk of irregular astigmatism.
"Our first task is to contact all those patients we've had to turn away from LASIK for medical reasons", Lewis said. "Staar Surgical has made it possible for almost all patients to dramatically reduce their dependence on glasses and contact lenses."
Dr. Lewis has been performing this procedure abroad during the last
five years and was one of the first surgeons certified by Staar.
www.fdanews.com/dailies/bulletin *article has expired
quote.bloomberg.com/apps/news
biz.yahoo.com/rc/031003/health_staar_2.html *article has expired
biz.yahoo.com/prnews/031007/sftu090_1.html *article has expired
icltv.com
Wills Welcomes Dr. James Lewis for LASIK.
Dr. Lewis will begin performing LASIK at Wills Eye Bucks County and perhaps other Wills Eye locations.
This is the first time Dr. Lewis has performed LASIK outside his own operating suites but it is not the first time he has worked with the Wills Eye Staff. In fact, half of each week he is in the Wills Eye Operating rooms of Bucks County, Plymouth Meeting, and NorthEast Philadelphia.
Dr. Lewis will be accompanied by his LASIK coordinators and surgical technicians to supplement the outstanding Wills Eye staff. (Some were originally members of the Wills Eye Family.)
"We are happy to add this option for our patients", Lewis said. "The Wills name stands for quality, excellence, and compassion in our area."
While there is additional cost to use this facility many patients prefer having LASIK in this setting. Feel free to call us for more information.
LASIKDVD has arrived!
Our complete LASIK Seminar on DVD has arrived.
Learn about LASIK at your own pace and in your own home.
View over 2 hours of surgery, staff interviews, testimonials, and post-operative evaluations filmed in our office.
Test your LASIK knowledge and
see Dr. Lewis in the OR and with patients.
Get your free copy here
and get free shipping directly to your home or office.
Call 888-700-EYES
Fax 215-893-8779
email free@lasikdvd.com
surf http://www.lasikdvd.com
Wavefront Analysis and LASIK
The 11 o'clock news just finished a brief report
on a new kind of LASIK. It is really "old news".
Each LASIK procedure, when done correctly, is customized.
We are the only center in Pennsylvania and South Jersey with the
equipment to measure your corneal wavefront.
Special techniques to maintain a prolate corneal contour (and thereby avoid glare) have been part of our standard surgery for years. i.e. no added cost!
Feel free to stop in and discuss LASIK and recent advances in surgery.
Schedule your free evaluation or get your free LASIKDVD and attend a full LASIK Seminar without leaving the comfort of your home.
Wavefront for LASIK arrives
We have obtained the first NIDEK OPD-SCAN ARK-10000 in the region. Recently approved by the FDA this Hartmann-Shack wavefront analyzer combines dynamic skiascopy, corneal topography, keratometry, autorefraction, and corneal refractive power analysis.
This device gives us a method of anticipating your post-operative QUALITY of VISION.
Wavefront data will make your decision to have LASIK more scientific.
Accurate and Reliable Data for Optic Diagnostics
The NIDEK OPD-Scan II provides information on corneal topography, wavefront, autorefraction, keratometry and pupillometry in one unit, utilizing state-of-the-art imaging and analysis technology developed specifically to measure normal to highly aberrated eyes.
The system offers a variety of data maps to provide information on the total refractive error, wavefront, corneal shape, internal aberrations and visual quality of the eye, allowing highly accurate and reliable information for optic diagnostics.
Learn more.
Nidek stomps Alcon's LADARVISION
NIDEK Wins Patent Case Against Alcon/Summit
-Gamagori, JAPAN, December 20, 2002-
NIDEK Co., Ltd. of Gamagori, Japan today announced that it has received a favorable ruling from the United States District Court for the District of Massachusetts, holding that NIDEK's EC-5000 does not infringe two patents owned by Summit Technology, Inc. Alcon Laboratories bought Summit Technology, Inc. in 2000.
In the case Summit Technology, Inc. v. NIDEK Co., Ltd., et al., a jury returned a verdict in favor of Summit in September 2002. NIDEK immediately filed a motion for judgment as a matter of law, asking the Court to overturn the verdict as legally insufficient on a number of grounds. NIDEK's motion to the Court demonstrated critical defects in Summit's proof of infringement. In a 31 page comprehensive opinion, District Court Judge Edward Harrington agreed with NIDEK, holding that no reasonable jury, having considered all of the evidence in the light most favorable to Summit, could have found that NIDEK's EC-5000 device infringed Summit's patents. Even under this most stringent standard, NIDEK prevailed and was not found to be infringing on Summit / ALCON patents.
The result of this ruling means that the jury's verdict has been completely overturned and vacated. Judgment as a matter of law that the EC-5000 does not infringe either Summit patents will be entered in NIDEK's favor. This ruling thus represents a complete victory for NIDEK in the trial court in this hard fought case.
"We are extremely pleased and grateful with this final decision from the court," stated Mr. Hideo Ozawa, President of NIDEK Co. Ltd. "The judge's ruling reaffirms our belief that the EC-5000 does not infringe on the patents of our competitors. NIDEK remains committed to its customers and, as a result of this ruling, NIDEK's customers are free to continue using their EC-5000 without the threat of an injunction. NIDEK is able to continue to market and sell the EC-5000 in the US market without interruption. NIDEK has over the last 30 plus years focused its efforts on developing new and innovative, quality products for the visioncare industry. We will continue our efforts to develop and introduce new products and solutions for the visioncare professional and their patients around the world," added Mr. Ozawa.
For further information contact:
Contact:
Public Relations, Planning Dept.
NIDEK Co., Ltd.
send your glasses on vacation
Test your LASIK IQ
New Va Team Portrait
Treat LASIK dry eye!
Learn more. Read all about it
click image to read article
Take a virtual tour of our LASER suite
Tiger Wood's surgeon uses
the same instrumentation.
We use the best microkeratome
to produce your LASIK flap.
Most specialists consider this the only way
to achieve an optimal LASIK result.
Click on the article below if you'd like to see what Tiger Wood's doctor, (Mark E. Whitten, MD) has to say.
He claims to have had fewer abrasions (pain), less DLK (inflammation), and greater consistency with the disposable micorkeratome by Moria.
This wasn't even available when Tiger had his LASIK!
Link to Moria Web Site
Many surgeons won't use this device
because it is so expensive!!
We think it is worth it.
We know you will too!
Demand the Moria One-Use Microkeratome
for the best possible LASIK results.
Large pupil treatment approved by FDA.
NIDEK Receives FDA Approval For Increased Optical Zone
Allows for Expanded Treatment Options in LASIK
-Fremont, CA, USA, November 6, 2001-
NIDEK, Inc. announced today that it has received supplemental pre-market approval from the U.S. Food and Drug Administration for the NIDEK EC-5000 Excimer Laser System to utilize an increased optical zone during the LASIK procedure. The NIDEK EC-5000 is now FDA-approved for a 6.5 mm optical zone in the treatment of myopia and myopia with astigmatism, as part of LASIK. This expanded optical zone may be used with a 7.5 mm transition zone in treating myopia and myopia with astigmatism using LASIK.
"Increasing the size of the optical zone approval opens the door for expanded treatment parameters and options on the EC-5000," commented Hiroshi Okada, vice president and general manager, NIDEK, Inc. "It is our continued endeavor to provide refractive surgeons with state-of-the-art tools to treat a broad range of refractive errors using our innovative, technologically advanced platform."
The increased optical zone will allow refractive surgeons greater ability to treat larger areas on the cornea during the LASIK procedure. This may also prove to be beneficial to patients who have pupils larger than normal, and were previously not candidates for LASIK.
At his state-of-the-art laser eye surgery Philadelphia facility, Dr. Lewis performs a variety of advanced vision correction procedures. In addition to offering LASIK, he has multiple years’ experience helping Philadelphia, Elkins Park and Bucks County Epi-LASIK and Visian ICL patients realize their dreams of clear vision without glasses.